FGFR2 Antibody Market: Targeting a Key Oncogenic Driver in...

добавлена новая статья Health

2026-07-30 07:28:46 -

FGFR2 Antibody Market: Targeting a Key Oncogenic Driver in Precision Oncology

Market Overview The FGFR2 antibody market is gaining momentum as fibroblast growth factor receptor 2 is increasingly recognized as a validated oncogenic driver in cholangiocarcinoma, gastric cancer, and other solid tumors. Research antibodies and therapeutic candidates targeting FGFR2 fusions, amplifications, and mutations are being developed by biopharma companies and supplied by life-science...

0 Комментарии 0 Поделились 5 Просмотры 0 предпросмотр